nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—ADRB1—periodontitis	0.969	1	CbGaD
Phenylpropanolamine—Pseudoephedrine—ADRB1—periodontitis	0.000875	0.513	CrCbGaD
Phenylpropanolamine—Pseudoephedrine—TNF—periodontitis	0.00083	0.487	CrCbGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—IL10—periodontitis	0.000131	0.00439	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—NRF2 pathway—AGER—periodontitis	0.000123	0.00415	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.000121	0.00408	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.000121	0.00406	CbGpPWpGaD
Phenylpropanolamine—DRD1—Circadian rythm related genes—NTRK1—periodontitis	0.000121	0.00406	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00012	0.00404	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.000117	0.00395	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CXCL3—periodontitis	0.000115	0.00386	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—CXCR2—periodontitis	0.000113	0.00382	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.000113	0.00381	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.000109	0.00366	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CXCL3—periodontitis	0.000107	0.00359	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.000107	0.00358	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.000106	0.00357	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.000105	0.00354	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.000104	0.00349	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.000103	0.00348	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—CXCR2—periodontitis	0.000102	0.00342	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—SERPINF2—periodontitis	0.000101	0.00338	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	9.71e-05	0.00327	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	9.33e-05	0.00314	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Phase II conjugation—GGT1—periodontitis	9.23e-05	0.0031	CbGpPWpGaD
Phenylpropanolamine—DRD1—Circadian rythm related genes—PPARA—periodontitis	9.14e-05	0.00307	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—CXCR2—periodontitis	9.14e-05	0.00307	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	9.13e-05	0.00307	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	9.09e-05	0.00306	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Platelet activation, signaling and aggregation—TIMP1—periodontitis	9.03e-05	0.00304	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	9.02e-05	0.00303	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—CXCR2—periodontitis	8.94e-05	0.00301	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CXCL3—periodontitis	8.92e-05	0.003	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—CCR2—periodontitis	8.83e-05	0.00297	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	8.82e-05	0.00296	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	8.78e-05	0.00295	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	8.19e-05	0.00275	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	8.16e-05	0.00274	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CXCL3—periodontitis	8.1e-05	0.00272	CbGpPWpGaD
Phenylpropanolamine—DRD1—Circadian rythm related genes—NOS2—periodontitis	8.08e-05	0.00272	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CXCL3—periodontitis	8.02e-05	0.0027	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—CCR2—periodontitis	7.91e-05	0.00266	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—ADRB1—periodontitis	7.87e-05	0.00265	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CXCL3—periodontitis	7.84e-05	0.00264	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	7.73e-05	0.0026	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—SLC52A3—periodontitis	7.64e-05	0.00257	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	7.55e-05	0.00254	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	7.53e-05	0.00253	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	7.52e-05	0.00253	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CXCR2—periodontitis	7.4e-05	0.00249	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CXCL3—periodontitis	7.28e-05	0.00245	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	7.22e-05	0.00243	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—CXCL8—periodontitis	7.14e-05	0.0024	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CXCL3—periodontitis	7.12e-05	0.00239	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—CCR2—periodontitis	7.11e-05	0.00239	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	7.02e-05	0.00236	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	6.99e-05	0.00235	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—CCR2—periodontitis	6.95e-05	0.00234	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—ADRB1—periodontitis	6.92e-05	0.00233	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CXCR2—periodontitis	6.87e-05	0.00231	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—IL1B—periodontitis	6.85e-05	0.0023	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Arachidonic acid metabolism—PTGS2—periodontitis	6.75e-05	0.00227	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	6.71e-05	0.00226	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCL3—periodontitis	6.49e-05	0.00218	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—VIP—periodontitis	6.45e-05	0.00217	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCL3—periodontitis	6.03e-05	0.00203	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—NRF2 pathway—TGFB1—periodontitis	5.89e-05	0.00198	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCL3—periodontitis	5.89e-05	0.00198	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—VIP—periodontitis	5.85e-05	0.00197	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—VIP—periodontitis	5.8e-05	0.00195	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CCR2—periodontitis	5.75e-05	0.00193	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CXCR2—periodontitis	5.75e-05	0.00193	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—ADRB1—periodontitis	5.73e-05	0.00193	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—VIP—periodontitis	5.67e-05	0.00191	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCL3—periodontitis	5.47e-05	0.00184	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Biological oxidations—GGT1—periodontitis	5.4e-05	0.00182	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CCR2—periodontitis	5.34e-05	0.0018	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—ADRB1—periodontitis	5.32e-05	0.00179	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—VIP—periodontitis	5.26e-05	0.00177	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—NRF2 pathway—TGFB1—periodontitis	5.22e-05	0.00176	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CXCR2—periodontitis	5.22e-05	0.00175	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	5.22e-05	0.00175	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CXCR2—periodontitis	5.17e-05	0.00174	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—VIP—periodontitis	5.15e-05	0.00173	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	5.12e-05	0.00172	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—SLC52A3—periodontitis	5.1e-05	0.00172	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CXCR2—periodontitis	5.05e-05	0.0017	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—TNF—periodontitis	4.97e-05	0.00167	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	4.87e-05	0.00164	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—periodontitis	4.87e-05	0.00164	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCL3—periodontitis	4.78e-05	0.00161	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CXCR2—periodontitis	4.69e-05	0.00158	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—VIP—periodontitis	4.69e-05	0.00158	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—TIMP1—periodontitis	4.66e-05	0.00157	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	4.6e-05	0.00155	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CXCR2—periodontitis	4.59e-05	0.00154	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—ACP5—periodontitis	4.5e-05	0.00151	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	4.5e-05	0.00151	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CCR2—periodontitis	4.47e-05	0.0015	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—ADRB1—periodontitis	4.45e-05	0.0015	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—VIP—periodontitis	4.36e-05	0.00147	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCL3—periodontitis	4.3e-05	0.00145	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—VIP—periodontitis	4.26e-05	0.00143	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCL3—periodontitis	4.21e-05	0.00141	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCR2—periodontitis	4.18e-05	0.00141	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CCR2—periodontitis	4.06e-05	0.00136	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	4.05e-05	0.00136	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—ADRB1—periodontitis	4.04e-05	0.00136	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CCR2—periodontitis	4.02e-05	0.00135	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—PPARA—periodontitis	4.01e-05	0.00135	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—IL6—periodontitis	4.01e-05	0.00135	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—VIP—periodontitis	3.96e-05	0.00133	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CCR2—periodontitis	3.93e-05	0.00132	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—ADRB1—periodontitis	3.91e-05	0.00132	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—CCL2—periodontitis	3.9e-05	0.00131	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCR2—periodontitis	3.88e-05	0.00131	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCR2—periodontitis	3.8e-05	0.00128	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	3.72e-05	0.00125	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CCR2—periodontitis	3.65e-05	0.00123	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	3.64e-05	0.00122	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CCR2—periodontitis	3.57e-05	0.0012	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	3.56e-05	0.0012	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—PPARA—periodontitis	3.56e-05	0.0012	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—ADRB1—periodontitis	3.55e-05	0.00119	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCR2—periodontitis	3.53e-05	0.00119	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—CCL2—periodontitis	3.5e-05	0.00118	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL3—periodontitis	3.48e-05	0.00117	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—VIP—periodontitis	3.46e-05	0.00116	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	3.46e-05	0.00116	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—CXCL8—periodontitis	3.44e-05	0.00116	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—CCL2—periodontitis	3.43e-05	0.00115	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CCR2—periodontitis	3.25e-05	0.00109	CbGpPWpGaD
Phenylpropanolamine—DRD1—Circadian rythm related genes—IL6—periodontitis	3.24e-05	0.00109	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—ADRB1—periodontitis	3.24e-05	0.00109	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL3—periodontitis	3.23e-05	0.00109	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—VIP—periodontitis	3.11e-05	0.00105	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCR2—periodontitis	3.08e-05	0.00104	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—CXCL8—periodontitis	3.08e-05	0.00104	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—MMP3—periodontitis	3.08e-05	0.00103	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—VIP—periodontitis	3.04e-05	0.00102	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CCR2—periodontitis	3.02e-05	0.00102	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—ADRB1—periodontitis	3.01e-05	0.00101	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ACP5—periodontitis	3.01e-05	0.00101	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CCR2—periodontitis	2.95e-05	0.000993	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	2.94e-05	0.00099	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—ADRB1—periodontitis	2.94e-05	0.000988	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—MMP1—periodontitis	2.9e-05	0.000974	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CCL2—periodontitis	2.83e-05	0.000953	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—SLC52A3—periodontitis	2.82e-05	0.000947	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCR2—periodontitis	2.77e-05	0.000932	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—CXCL8—periodontitis	2.77e-05	0.000931	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—MMP3—periodontitis	2.76e-05	0.00093	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCR2—periodontitis	2.74e-05	0.000922	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	2.73e-05	0.00092	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—ADRB1—periodontitis	2.73e-05	0.000918	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCR2—periodontitis	2.71e-05	0.000912	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—CXCL8—periodontitis	2.71e-05	0.000911	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—MMP3—periodontitis	2.7e-05	0.00091	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—periodontitis	2.69e-05	0.000906	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CCL2—periodontitis	2.63e-05	0.000886	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—NOS2—periodontitis	2.61e-05	0.000878	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—VIP—periodontitis	2.52e-05	0.000846	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—GGT1—periodontitis	2.5e-05	0.000842	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCR2—periodontitis	2.4e-05	0.000806	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—ADRB1—periodontitis	2.39e-05	0.000803	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—VIP—periodontitis	2.34e-05	0.000786	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCR2—periodontitis	2.24e-05	0.000754	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CXCL8—periodontitis	2.24e-05	0.000754	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—MMP3—periodontitis	2.24e-05	0.000752	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	2.23e-05	0.000751	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCR2—periodontitis	2.16e-05	0.000725	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCR2—periodontitis	2.11e-05	0.000709	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—ADRB1—periodontitis	2.1e-05	0.000706	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCR2—periodontitis	2.08e-05	0.000701	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CXCL8—periodontitis	2.08e-05	0.0007	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—MMP3—periodontitis	2.08e-05	0.000699	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	2.07e-05	0.000697	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CCL2—periodontitis	2e-05	0.000672	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NTRK1—periodontitis	1.95e-05	0.000657	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MMP3—periodontitis	1.82e-05	0.000611	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CCL2—periodontitis	1.8e-05	0.000605	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PPARA—periodontitis	1.79e-05	0.000603	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CCL2—periodontitis	1.76e-05	0.000591	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NTRK1—periodontitis	1.76e-05	0.000591	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCR2—periodontitis	1.74e-05	0.000586	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CXCL8—periodontitis	1.74e-05	0.000585	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ADRB1—periodontitis	1.74e-05	0.000584	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NTRK1—periodontitis	1.72e-05	0.000578	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—GGT1—periodontitis	1.67e-05	0.000562	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ACP5—periodontitis	1.66e-05	0.000558	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MMP3—periodontitis	1.63e-05	0.000549	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCR2—periodontitis	1.62e-05	0.000545	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ADRB1—periodontitis	1.61e-05	0.000542	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MMP3—periodontitis	1.6e-05	0.000537	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CXCL8—periodontitis	1.58e-05	0.000532	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CXCL8—periodontitis	1.57e-05	0.000526	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CXCL8—periodontitis	1.53e-05	0.000515	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.48e-05	0.000499	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CCL2—periodontitis	1.45e-05	0.000489	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NTRK1—periodontitis	1.42e-05	0.000478	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CXCL8—periodontitis	1.42e-05	0.000478	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CXCL8—periodontitis	1.39e-05	0.000468	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—TGFB1—periodontitis	1.39e-05	0.000467	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCL2—periodontitis	1.35e-05	0.000455	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MMP3—periodontitis	1.32e-05	0.000444	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NTRK1—periodontitis	1.32e-05	0.000444	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCL8—periodontitis	1.27e-05	0.000426	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MMP3—periodontitis	1.23e-05	0.000413	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PPARA—periodontitis	1.2e-05	0.000403	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCL2—periodontitis	1.18e-05	0.000397	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCL8—periodontitis	1.18e-05	0.000396	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PTGS2—periodontitis	1.16e-05	0.000392	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCL8—periodontitis	1.15e-05	0.000387	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCL8—periodontitis	1.07e-05	0.000359	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—FGF2—periodontitis	1.07e-05	0.000359	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL2—periodontitis	1.06e-05	0.000357	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL2—periodontitis	1.04e-05	0.000349	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	9.65e-06	0.000324	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—FGF2—periodontitis	9.6e-06	0.000323	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—FGF2—periodontitis	9.39e-06	0.000316	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCL8—periodontitis	9.34e-06	0.000314	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GGT1—periodontitis	9.23e-06	0.000311	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL6—periodontitis	8.88e-06	0.000299	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL2—periodontitis	8.59e-06	0.000289	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MMP9—periodontitis	8.45e-06	0.000284	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCL8—periodontitis	8.4e-06	0.000282	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCL8—periodontitis	8.21e-06	0.000276	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL6—periodontitis	7.98e-06	0.000268	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL2—periodontitis	7.98e-06	0.000268	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL6—periodontitis	7.81e-06	0.000263	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PTGS2—periodontitis	7.78e-06	0.000262	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FGF2—periodontitis	7.77e-06	0.000261	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MMP9—periodontitis	7.59e-06	0.000255	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MMP9—periodontitis	7.43e-06	0.00025	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FGF2—periodontitis	7.22e-06	0.000243	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TGFB1—periodontitis	6.96e-06	0.000234	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL8—periodontitis	6.79e-06	0.000228	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PPARA—periodontitis	6.61e-06	0.000222	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL6—periodontitis	6.46e-06	0.000217	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL8—periodontitis	6.31e-06	0.000212	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TGFB1—periodontitis	6.26e-06	0.00021	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MMP9—periodontitis	6.14e-06	0.000207	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TGFB1—periodontitis	6.12e-06	0.000206	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6—periodontitis	6e-06	0.000202	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MMP9—periodontitis	5.71e-06	0.000192	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6—periodontitis	5.25e-06	0.000176	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TGFB1—periodontitis	5.06e-06	0.00017	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6—periodontitis	4.72e-06	0.000159	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TGFB1—periodontitis	4.71e-06	0.000158	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6—periodontitis	4.61e-06	0.000155	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTGS2—periodontitis	4.3e-06	0.000144	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6—periodontitis	3.82e-06	0.000128	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6—periodontitis	3.55e-06	0.000119	CbGpPWpGaD
